International Patent: ENGINEERED IMMUNE CELLS EXPRESSING ANTI-EPHA2 ANTIBODIES AND USES THEREOF

GENEVA, Sept. 18 -- MEMORIAL SLOAN-KETTERING CANCER CENTER filed a patent application (US2026/017277) for “ENGINEERED IMMUNE CELLS EXPRESSING ANTI-EPHA2 ANTIBODIES AND USES THEREOF”. With publication no. WO/2026/187657, here are the other details related to the patent application:

Kind: Initial Publication without ISR [A2]

IPC: none

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....